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Pre-eclampsia (PE) is a major cause of maternal and perinatal morbidity and mortality
worldwide. It is defined by new onset of hypertension and proteinuria after the 20th week of
gestation and characterized by systemic exaggerated inflammatory response. D6 is a che-
mokines scavenger receptor that binds with high affinity CC chemokines, internalizes and
targets the ligands for degradation. It is expressed in trophoblast-derived tissues and pre-
vents excessive placenta leukocyte infiltration.The aim of this study was to investigate the
expression and function of D6 in human placentae from pre-eclamptic and healthy pregnant
women.
Methods and Results
Plasma levels of D6-binding CC chemokines (CCL-2, CCL-3, CCL-4, CCL-7, CCL-11) and
pro-inflammatory cytokines (IL-6, TNF-α, CRP) were analyzed in 37 healthy pregnant
women and 38 patients with PE by multiplex bead assay. Higher circulating levels of CCL7,
CCL11, IL-6, (p<0.0001) and CRP (p<0.05) were observed in PE women compared to con-
trols. Levels of circulating CCL4 were decreased in PE (p<0.001), while no significant differ-
ences of CCL2, CCL3 or TNF-α levels were detected. Immunofluorescent staining of
placental sections showed higher expression of D6 receptor in the PE syncytiotrophoblast.
Confocal and Western blot (WB) analyses revealed a prevalent distribution of D6 in tropho-
blast cells membranes in PE. Increased activation of D6 intracellular pathway was
observed by Western blot analyses of p-LIMK and p-cofilin in trophoblast cell lysates. D6
functional assays showed reduced scavenging of CCL2 in PE cells compared to controls.
Since actin filaments spatial assembling is essential for D6 intracellular trafficking and scav-
enging activity, we investigated by confocal microscopy trophoblast cytoskeleton organiza-
tion and we observed a dramatic disarrangement in PE compared to controls.
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Conclusions
our results suggest membrane distribution of D6 receptor on trophoblast cell membranes in
PE, together with reduced functionality, probably due to cytoskeleton impairment.
Introduction
Pre-eclampsia (PE) is a pregnancy-specifichypertensive disorder defined as new onset hyper-
tension and proteinuria at or after 20 weeks’ gestation [1]. Complicating 2–8% of all pregnan-
cies, PE is a major cause of maternal morbidity and mortality and of adverse perinatal
outcomes [2]. The underlying causes remain unclear but it is recognized to be a placenta-
driven disorder associated with poor placental perfusion causing hypoxia-reperfusion injury
and oxidative syncytiotrophoblast stress. Release into the maternal circulation of placental pro-
inflammatory and anti-angiogenic factors ensues, leading to endothelial dysfunction, exagger-
ated maternal inflammatory response and hypercoagulability [3–5].
The systemic inflammatory response occurring in overt PE involves leukocytes, the clotting
and complement systems and the endothelium. Communication between these various com-
ponents of the inflammatory network is facilitated by a large variety of secreted proteins such
as cytokines. Among these, chemokines are essential for leukocyte chemoattraction [6,7].
Chemokines promote leukocytes recruitment to sites of infection and inflammation by acti-
vating conventional G protein-coupled receptors [8,9]. They are also recognizedby a set of
atypical chemokine receptors (ACRs) that cannot induce directional cell migration but are
required for the generation of chemokine gradients in tissues. ACRs are considered "silent
receptors" because no G protein-dependent signaling activity is observed after their engage-
ment by cognate ligands [10,11].
D6 decoy receptor is one of the ACRs. It binds most inflammatory, but not homeostatic, CC
chemokines, internalizes constitutively, and targets the ligand for degradation [12,13].
In resting conditions, D6 is predominantly located in intracellular/perinuclear compart-
ments and only 5% is detectable on the cell surface [14,15]. After chemokines binding, D6 is
constitutively internalized and then targeted to early endosomes [12,16]. Once D6 has been
internalized, ligands dissociate from the receptor and are targeted to degradation in lysosomal
compartments, while the receptor is free to recycle back to the cell surface [15–17] with mecha-
nisms that are strictly dependent on cytoskeleton dynamics [18].
Indeed, the engagement of D6 receptor by its ligands activates a β-arrestin1-dependentG
protein-independent signaling pathway, the Rac1-p21-activated kinase 1 (PAK1)-LIM kinase 1
(LIMK1) cascade [18]. This cascade results in the phosphorylation and inactivation of a major
actin-depolymerizing factor, cofilin, that enable actin network rearrangements that are criti-
cally required for the increased abundance of D6 protein on the cell surface and for its chemo-
kine-scavenging activity [18].
Differently from other chemokine receptors, D6 expression has been reportedmainly in
non-hematopoietic cells and includes endothelial cells lining afferent lymphatic in skin, gut,
and lung [19]. D6 expression has been also detected in the human placenta [20], particularly
concentrated toward the apical surface of chorionic villous trophoblast, the side directly con-
tactingmaternal blood [21].
Recently, a role for D6 decoy receptor activity in the maintenance of controlled inflammatory
placental environment at maternal-fetal interface has been proposed by Martinez de la Torre and
co-authors, who showed that trophoblast cells express D6 and use this molecule to scavenge
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inflammatoryCC chemokines [22]. Intriguingly, they also provided evidences that D6 is required
to prevent excessive placenta leukocyte infiltration and inflammation- and autoantibody-induced
fetal loss in animal models, thus protecting the fetus frommiscarriage [22]. Consistently, Madi-
gan et al. have demonstrated that, in normal pregnancy, despite robust expression of pro-inflam-
matory chemokines by gestational tissues, D6-binding chemokines are less abundant in maternal
plasma compared to non-pregnant women. Indeed, maternal blood continuously flows towards
D6-expressing chorionic villi, suggesting a crucial role for D6 decoy receptor in blood chemo-
kines scavenging and regulation of local and systemic inflammation [21].
Conversely, a trend of increase in circulating D6-binding chemokines was observed in the
third trimester in 34 women later developing PE compared to gestational age-matched con-
trols [21].
Since PE is a placental-induced inflammatory disorder characterized by higher circulating
blood levels of pro-inflammatory cytokines, like CCL2, IL-6, IL-8, TNF-α, RANTES (or CCL5)
and MIF (macrophage migration inhibitory factor) [21, 23–27], the aim of this study was to
investigate a possible abnormal expression or function of placental D6 receptor, and thus, of a
pivotal regulatory system of tissue inflammatory response, in human placentae obtained from
women with PE compared to women with physiological pregnancy.
With this purpose, we collected blood and placentae from 37 pre-eclamptic and 38 healthy
pregnant women at delivery and we quantified circulating pro-inflammatory cytokines (IL-6,
TNF-α, CRP) and chemokines, specifically scavenged by D6 receptor (CCL-2, CCL-3, CCL-4,
CCL-7, CCL-11). Placental lysates and placental sections were investigated for D6 expression
by Western blot analysis and immunofluorescent staining, respectively. Primary trophoblast
cells obtained from PE women and controls were analyzed for D6 cellular distribution by con-
focal microscopy andWestern blot analysis. Furthermore, we investigated the functional activ-
ity of D6 in trophoblast cells by both binding and scavenging assays of CCL-2 (D6-binding
chemokine).Finally, we analyzed trophoblast actin fibers organization, whose integrity is cru-
cial for D6 internalization and scavenging.
In the complex, our data indicates that D6 is concentrated on trophoblast cell membranes
in PE, in line with higher circulating levels of D6-ligand chemokines, but its scavenging activity
is affected by trophoblast cytoskeleton disarrangement.
Materials and Methods
Patients and Samples
Maternal blood samples (5 ml) from healthy pregnant women (n = 38) or PE (n = 37) were col-
lected by vein puncture just before delivery and spun at 3000g at 4°C for 20 minutes. The
supernatant were then aliquoted and immediately stored at -80°C until use.
Placentae were collected from 10 women with normal pregnancies undergoing caesarean
section for breech presentation, and 10 women with PE immediately after delivery. None of the
women recruited in this study were in labor at the time of placental sampling and all had sin-
gleton pregnancies with no known fetal abnormalities.Women with diabetes, autoimmune dis-
eases or infections or sepsis were excluded from the study.
Placental biopsies were taken for being either mechanically disrupted by sonication and
stored in Hepes Lysis Buffer at -20°C or embedded in parafolmadehyde for 12 hours and then
in ethanol at R/T. Remnant placental tissues were used for primary trophoblast cultures as
detailed below.
These studies were approved by the Ethics Committee of the Catholic University of Sacred
Heart, Rome, Italy and have been conducted according to the delclaration of Helsinki.
Informed written consent was obtained from all participants.
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Multiplex Bead Assay
Plasma levels of pro-inflammatory cytokines (IL-6, TNF-α, CRP) and D6-binding chemokines
(CCL-2, CCL-3, CCL-4, CCL-7, CCL-11) were analyzed using a Multiplex Bead Array System,
Procarta1 Immunoassay Kit (Diametra,Milan, Italy), according to manufacturer’s instruc-
tions. The analyses of levels of cytokines were made using the Luminex 100 instrument (Lumi-
nex Corp., Austin, TX, USA) and STarStation software (V1.1, Applied Cytometry Systems,
Sheffield, UK).
Immunofluorescent Staining
Placental sections were deparaffinisedby washing for 1 minute each in Histo clear 1 and Histo
clear 2 solutions before being rehydrated in a series of washes in 100% (x2), 95%, 90%, 80%,
70% and 50% alcohol solutions. Slides were dipped in sodium citrate (VWR, UK) buffer
(10mM, pH 6.0) for 10 minutes in a microwave oven, cooled at R/T for 30 minutes and then
washed in PBS before being incubated in a blocking solution comprising of PBS containing
10% (v/v) FCS for 1 hour at R/T. Experimental sections were then incubatedO/N at 4°C in
PBS containing 1% FCS and 20μg/ml of D6 primary rat monoclonal antibody (R&D Systems).
After 3 washings in 0.01% PBS-T of 10 minutes each, placental sections were stained with sec-
ondary FITC-conjugated goat anti-rat antibody (Life Technologies, UK) at 1:400 dilutions for
1 hour at R/T. Sections were then washed three times for 10 minutes each with 0.01%
PBS-Tand mounted under microscopic glass coverslips in Prolong1 Gold Antifade Reagent
and evaluated by an inverted-phase fluorescent microscope (2003; Axiover 35, Zeiss). Images
were acquired with a digital camera (Nikon Coolpix 4500).
RNA Isolation and Real Time PCR
Total RNA was isolated from control and PE placental tissues using TRIzol reagent (Life Tech-
nologies, Invitrogen, Italy) according to manufacturer’s instructions.Genomic DNA contami-
nation was removed by DNAse I digestion before RT-PCR. cDNA was generated from 5 μg of
total RNA using a random hexamers approach and RevertAidHMinus First Strand cDNA
Synthesis kit (Fermentas, Italy).
Gene expressions levels of D6 were determined by Real Time PCR using specific TaqMan
primers and probe (CCBP2 hs00174299 m1, Life Technologies, Italy). mRNA levels were nor-
malized using endogenous 18s as internal reference (Life Technologies, Italy). Relative expres-
sion and fold change were calculated according to Livak and Schmittgen [28].
Primary Trophoblast Cells Culture
Based on the characteristic syncytiotrophoblast distribution of D6 in placental sections, to
investigate D6 expression in primary trophoblast cells from PE and controls (CTR), placentae
were collected from 10 PE and 10 CTR patients and cytotrophoblast cells were isolated as
detailed elsewhere [29]. Cells`viability, assessed by trypan blue dye exclusion, was 90%. The
purity of the cell preparation was evaluated by immunohistochemical staining for markers of
a) macrophages (3%, determined using a polyclonal anti-a1-chymotrypsin antibody;Dako,
Santa Barbara, CA,USA); b) fibroblasts (2%, determined using a polyclonal anti-vimentin anti-
body; Labsystems, Helsinki, Finland); and c) syncytiotrophoblast (1% determined using a
monoclonal antibody against low molecular weight cytokeratins; Labsystems, Chicago, IL,
USA). The enriched (95%) trophoblast cells were cultured in Dulbecco’s modifiedEagle’s
medium (DMEM, Sigma-Aldrich, St. Louis, MI,USA) with 10% fetal bovine serum (FBS,
Sigma) at 37°C in 5% CO2/95% air for 48 hours.
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Confocal Microscopy Analysis of D6 Expression in Trophoblast Cells
To quantify and localizeD6, trophoblast cells were seeded on glass bottom dishes (Ibidi, Ger-
many, 5 x 104 cell/dish). After 24 hours cells were rinsed twice in PBS, fixed with 4% PFA for
10 minutes at room temperature (R/T) and, then, incubated for 1 hour at R/T with primary
anti-D6 antibody (10 μg/ml of rat monoclonal anti-human D6, R&D Systems, USA) and then
with secondary goat anti-rat Alexa Fluor1 488 conjugated antibody (Life Technologies, UK) at
1:400 dilutions for 1 hour at R/T.
All stainings were visualized by an inverted confocal microscope (SP2 LeicaMicrosystems,
Wetzlar, Germany) using a 40/1.25 NA oil objective and processed using LCS software version
2.61 (LeicaMicrosystems). Internal photon multiplier tubes collected images in 8-bit, unsigned
images at a 400-Hz scan speed. PMT was kept always at the same operating voltage during the
experiment. FITC was excited with an Ar/Kr laser line (excitation wavelength: 488 nm, emis-
sion range: 500–560 nm). Analysis of acquired images (fluorescence intensity evaluation on
cell membranes and on the interior part of the cell) was performedwith Image-J (NIH). Fluo-
rescence values for plasma membranes were determinedwithin multiple regions of interest
(ROI) for each sample. Free hand ROIs were drawn on cell membranes in transmission images
and transposed on fluorescence images for measurements as previously described [30]. Traced
ROIs were characterized by a length of several microns, and by a pixel resolution width. For
each sample n = 50 cells were analyzed.
Western Blot Analysis
Placental lysates and cell lysates were obtained by sonication. Plasma membranes (post-nuclear
particulate fractionwithout cytosolic components) from trophoblast cells were isolated as
described elsewhere [31]. Briefly, cell pellet was resuspended in 2,5 ml of ice-cold buffer (250
mM sucrose, 20 mMHEPES, pH 7.4, 2 mM EGTA, 3 mMNaN3) containing freshly added
protease inhibitors (200 μM pheylmethylsulphonylfluoride and 1 μM leupeptin; Sigma) and
homogenized in a 5ml glass Dounce homogenizer. The homogenate was centrifuged at 700 g
for 5 min to remove nuclei and unbroken cells and the resultant supernatant was centrifuged at
236,000 x g for 60 min to pellet cell membranes. The membranes were resuspended in homoge-
nizing buffer and frozen at -80°C until use. Protein concentration was measured by BCA.
For Western blotting, eighty μg of placenta, trophoblast cell or membrane lysates from PE
or CTR were separated by 10% SDS–PAGE electrophoresis under reducing conditions. After
gel electrophoresis and transfer of proteins to a nitrocellulosemembrane, nitrocellulose sheets
were blocked at R/T for 1 h in 5% non-fat drymilk. Placental lysates were incubated overnight
at +4°C with rat primary anti human D6 antibody (dilution 1:1000; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and mouse anti-actin antibody (dilution 1:500; Thermo Fisher Scien-
tific,Waltham, MA, USA) as loading control. Trophoblast cell lysates were incubated overnight
at +4°C with anti human D6 antibody and mouse anti human Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) antibody (dilution 1:1000; Abcam, Cambridge, UK), a cytoplasmic
protein. Membrane lysates were incubated overnight at +4°C with anti D6 antibody, anti
GAPDH antibody and anti human E-Cadherin antibody (dilution 1:1000; Cell Signaling Tech-
nology Inc., Danvers, MA, USA).), a plasma membrane marker. For intracellular D6 pathway
investigation, trophoblast cell lysates only were incubated with 5 μg/ml of specific primary
mouse anti p-LIMK [thr508] or anti p-Cofilin [ser3] antibody (Cell Signaling Technology Inc.,
Danvers, MA, USA).
After incubation with primary antibodies,membranes were washed with PBST and incu-
bated in specific horseradish peroxidase-conjugated secondary antibody diluted 1:2000 in 5%
non-fat driedmilk in PBST. Following incubation with secondary antibody, the immuno-
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complexes were visualizedwith ECL-Plus detection System (Amersham Biosciences Corp.
USA) according to manufacturer's instruction.Bands were analyzed using the Gel Doc 200 Sys-
tem (Bio-Rad Laboratories,Milan, Italy) and quantified by Quantity One quantitation Software
(Bio-Rad).
CCL2-D6 Binding Assay
Trophoblast cells obtained from PE and control placentae were seeded on glass bottom dishes
(Ibidi, Germany, 5 x 104 cell/dish) and incubated, according to manufacturer’s instructions,
with biotinylated human CCL2 (R&D systems) for 60 min at 2–8°C. Avid-FITC reagent for
additional 30 min at 2–8°C in the dark was added. Cells were then rinsed three times in 1X PBS
and visualized by an inverted confocal microscope (SP2; LeicaMicrosystems, Germany) with a
63x oil immersion objective (NA 1.4). Z-planes were acquired every 300 nm from the bottom
to the top of cells. Spot counting was performed on every plane by using image-J (NIH), and
the total number of spots was calculated for each cell as described elsewhere [32].
D6 Scavenging Assay
Trophoblast cells obtained from PE and control placentae were plated the day before the exper-
iment in 96-well plates (5 × 104 cells/well) and then incubated with 10 ng/mL of recombinant
CCL2 (D6 ligand, R&D Systems) for 12 or 24 hrs. The supernatant was collected and the che-
mokine concentration was evaluated at different times of incubation (0-12-24 hrs) by sandwich
ELISA (R&D Systems) according to manufacturer’s instructions.
F-Actin Immunofluorescent Staining
To investigate trophoblast cells cytoskeleton organization, cells from PE or control placentae,
primary cell cultures were seeded on glass bottom dishes (Ibidi, Germany, 5 x 104 cell/dish) in
DMEMwith 10% FBS. After cells were rinsed twice in PBS, fixed with 4% PFA for 10 min at
R/T, and permeabilizedwith 0.1% Triton-X for 5 min. Next, cells were incubated with Phalloi-
din Fluorescein Isothiocyanate Labeled according to manufacturer’s instructions for 30 min at
R/T (Sigma-Aldrich,USA). F-actin fibers were visualized by an inverted confocal microscope
(SP2; LeicaMicrosystems) with a 63x oil immersion objective (NA 1.4).
Statistical Analysis
Means and Standard Deviation (SD) or Medians and Minimum-Maximum ranges were used
to describe quantitative variables whereas absolute and relative frequencies were employed for
categorical ones. Data from in vitro experiments were analysed using one-way analysis of vari-
ance (ANOVA) followed by a post-hoc test (Bonferroni test). The results are shown as the
mean ± standard error (SE). For all analyses, p<0.05 was considered significant. Cytokines
plasma levels and clinical characteristics of PE and CTR women were compared by Chi square
test or MannWhitney test according to the type of variables. P value<0.05 was considered sta-
tistically significant.
Results
The clinical characteristics of PE patients and healthy pregnant women enrolled in this study
are reported in Tables 1 and 2. Pre-eclamptic women showed, as expected, higher bodymass
index (BMI) (p<0.001), lower gestational age at delivery (p<0.001) and lower neonatal birth
weight (p<0.001) compared to controls.
Chemokine Receptor D6 and Preeclampsia
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Pre-Eclamptic Patients Show Higher Plasma Levels of D6-Binding
Chemokines
Higher circulating levels of chemokines CCL7 (p<0.001) and CCL11 (p<0.001) as well as cyto-
kines IL-6 (p<0.001) and CRP (p<0.05) were observed in pre-eclamptic women compared to
healthy pregnant women (p<0.001). Levels of circulating CCL4 were found to be lower in PE
women compared to controls (p<0.001) while no significant differences were observed in
terms of CCL2, CCL3 or TNF-α(p = 0.7, p = 0.4 and p = 0.05, respectively) blood levels
between PE and healthy pregnant women (Table 3).
D6 Decoy Receptor Shows a Syncytiotrophoblast Distribution in
placentae from Pre-Eclamptic Women
Immunofluorescent staining for D6 decoy receptors of placental sections obtained revealed a
more intense staining in placentas obtained from women with PE compared to CTR with a
characteristic distribution in syncytiotrophoblast cells monolayer surrounding the chorionic
villi (Fig 1A and 1B).
Real Time PCR and WB Analysis of D6 in Placental Lysates
Quantitative analysis of D6 decoy receptor transcription or expression of whole placental
lysates did not show any significant difference betweenCTR and PE (Fig 1C and 1D).
WB Analysis of D6 in Trophoblast Cell Cultures
Quantitative analysis of D6 decoy receptor expression in lysates of primary trophoblast cells
cultured for 48 h did not show any significant difference betweenCTR and PE (S1 Fig).
Table 1. Characteristics of patients enrolled in the study.
Characteristics Pre-eclampsia (n = 37) Control (n = 38) P
Age (years) 34 (24–44)** 33 (21–44)** 0.54
Ethnic group
• Caucasian 35 (94.6%) 32 (84.2%) 0.19
• Afro-Caribbean 2 (5.4%) 6 (15.8%)
Nulliparous 24 (64.9%) 17 (44.7%) 0.10
BMI at booking (Kg/m2) 25.8 (7.2)* 22.2 (4.6)* <0.001
Preeclampsia onset
• Early 14 (41.2%) N/A
• Late 20 (58.8%) N/A
Uterine artery Doppler velocimetry
• Normal 12 (32.4%)
• Abnormal 24 (64.9%)
• Not performed 1 (2.7%) 38 (100%)
Gestational age at delivery (weeks) 34 (23–41)** 40 (37–41)** <0.001
Birth weight (g) 1650 (970)* 3450 (360)* <0.001
• SGA 18 (48.6%) 0 (0.0%) <0.001
• AGA 19 (51.4%) 38 (100.0%)
*Mean (Standard Deviation).
**Median (Minimum-Maximum); N/A: not applicable. SGA: small for gestational age. AGA: appropriate for gestational age.
doi:10.1371/journal.pone.0164747.t001
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D6 Decoy Receptor Displays a Membrane Distribution in Trophoblast
Cells in PE
As shown in Fig 2, in trophoblast cells from CTR, D6 receptor was mainly localized in intracel-
lular compartments (Fig 2, panels A and A.1), while in PE D6 showed a striking higher distri-
bution in trophoblast membranes (Fig 2, panels B and B.1 and S2 Fig). Fig 2C and 2D.
Table 2. Clinical details of the patients who donated placentas for in vitro studies.
Patients Gestation(weeks+days) Parity Age(years) Maximum BP(mmHg) Proteinuria(mg/dL) Birth Weight(g) Percentile(˚)
Normal pregnant partecipants
N1 39+1 0+0 28 125/80 N/D 3180 53
N2 39+3 2+0 31 120/80 N/D 3760 84
N3 39+4 0+0 35 115/70 N/D 3480 68
N4 39+1 1+0 34 110/80 N/D 2940 33
N5 39+2 1+0 32 120/80 N/D 3500 78
N6 39+0 0+0 32 125/80 N/D 3250 58
N7 39+3 0+0 28 110/70 N/D 3100 37
N8 39+5 2+0 26 120/80 N/D 3660 83
N9 39+3 0+0 29 110/80 N/D 2800 22
N10 39+5 0+0 34 110/80 N/D 3360 59
Pre-eclamptic partecipants
PE1 37+0 0+0 32 140/95 1.8 2240 10
PE2 39+3 0+0 29 160/100 0.5 2940 23
PE3 31+5 0+0 34 180/110 1.5 1300 10
PE4 33+2 1+0 35 160/100 1.0 1700 17
PE5 37+4 1+0 37 200/130 1.9 1990 8
PE6 22+1 0+0 27 170/110 1.0 350 -
PE7 33+2 0+0 27 155/100 3.5 1490 10
PE8 39+3 0+0 32 145/105 0.4 3560 75
PE9 30+0 0+3 38 130/100 0.5 910 9
PE10 36+4 0+0 24 145/95 0.7 3000 59
N: normal pregnant women. PE: pre-eclamptic women. BP: blood pressure. N/D: not detected. N/P: not performed.
doi:10.1371/journal.pone.0164747.t002
Table 3. Circulating levels of D6-binding chemokines and pro-inflammatory cytokines in women with pre-eclampsia and in healthy pregnant
women.
Chemokines Pre-eclampsia (n = 37) Control (n = 38) P
CCL2 (pg/ml) 15.6 (3.2–65.4) 15.9 (1.3–39.8) 0.7
CCL3 (pg/ml) 1.9 (0.3–5.7) 1.9 (0.3–8.2) 0.4
CCL4 (pg/ml) 230.6 (17.8–2086.7) 292.9 (43.1–827.8) <0.001
CCL7 (pg/ml) 22.9 (4.6–180.4) 4.6 (4.6–70.4) <0.001
CCL11 (pg/ml) 33.4 (0.6–84.7) 20.7 (3.3–56.7) <0.001
IL-6 (pg/ml) 1.5 (0.4–21.7) 0.7 (0.2–9.7) <0.001
TNF-α (pg/ml) 0.3 (0.3–7.5) 0.2 (0.3–8.5) 0.05
CRP (mg/ml) 3.6 (63.9–0.3) 1.2 (36.6–0.3) <0.05
Luminex assays revealed significantly increased levels of CCL7, CCL11, IL-6 and CRP, and decreased levels of CCL4 in serum samples of PE women
versus controls (CTR). Results are expressed as median (minimum-maximum range) of four experiments. P value <0.05 was considered statistically
significant.
doi:10.1371/journal.pone.0164747.t003
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Quantitative analysis of D6 expression by confocal microscopy andWB analysis confirmed
higher concentration of D6 on trophoblast cell membranes in PE compared to controls.
D6 Intracellular Pathway Is Over-Activated in Trophoblast Cells from PE
Placentae
WB analysis of trophoblast cell lysates from PE or CTR placentae showed increased phosphor-
ylation of cofilin through LIMK1 phosphorilation cascade (Fig 3A and 3B), an intracellular
Fig 1. Representative images of immunofluorescent staining for D6 in placental sections from (A) a normal pregnant woman at term or (B) a
woman with PE at 28 weeks of gestation. Characteristic positive expression for D6 receptor was detected in the syncytiotrophoblast monolayer in PE
(B). Scale bar 100 μm. No significant differences were found between PE and control placental lysates in terms of overall D6 tissue expression by
RT-PCR (C) or Western blot analysis (D). Results are expressed as mean ± SE of six experiments. NS: not significant.
doi:10.1371/journal.pone.0164747.g001
Chemokine Receptor D6 and Preeclampsia
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signaling required for cofilin inactivation and actin network rearrangement, essential for D6
scavenging activity.
CCL2 Chemokine Binding to Trophoblast Cells Is Reduced in PE
Confocal analysis of CCL2 binding to primary trophoblast cell culture from PE and controls
revealed a lower intensity of signaling in PE compared to controls, suggesting a reduced D6
receptor availability to chemokines in PE (Fig 4A and 4B), although its increasedmobilization
on cell membranes, probably due to saturation by chemokines previously occurred on tropho-
blast cells in vivo.
D6 Scavenging Activity Is Significantly Reduced in PE
Functional assay of D6 receptor scavenging activity in trophoblast cell cultures showed in both
controls and PE cells a significant scavenging of CCL2 after 12 and 24 hours of incubation
Fig 2. Representative image of D6 expression in primary trophoblast cell cultures from normal pregnant women (A and A1) or a women with
PE (B and B1) assessed by confocal microscopy. Cells from PE patients showed a more intense expression of D6 (green) on cell membranes
together with a more diffuse cytoplasm distribution compared to control cells, which displayed atypical speckled cytoplasmic D6 positivity. A and B: D6
fluorescent staining. A1 and B1: D6 overlay between fluorescent staining and electronic transmission. Scale bar 20 μm. Quantification of D6 expression
on trophoblast cell membranes was performed by (C) confocal analysis of fluorescence on membranes, as percentage of the whole cells fluorescence,
and (D) Western blot analysis of D6 on cell membrane lysates. Expression of both 46 and 49 KDa isoforms of D6 was increased in trophoblast
membranes in PE. Results are expressed as mean ± SE of six experiments.*p<0.05; ***p<0.001.
doi:10.1371/journal.pone.0164747.g002
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(p<0.05 versus time 0) (Fig 4D). Interestingly, after 24 hours a significant decrease of CCL2
scavenging activity was observed in cells from PE compared to CTR (§p<0.05 versus CTR).
Cytoskeleton Organization Is Impaired in PE Trophoblast Cells
Confocal analysis of trophoblast cells cytoskeleton organization performed by intracellular F-
actin FITC-staining showed a dramatic disarrangement and loss of spatial orientation of actin
fibers in PE compared to controls (Fig 5).
Discussion
D6 is a scavenger receptor that binds with high affinity CC chemokines, internalizes and targets
the ligands for degradation [6,7]. It has been proposed to have a central role in controlling the
inflammation at the maternal-fetal interface [22] since it is expressed in placenta on invading
extravillous trophoblast and on the apical side of syncytiotrophoblast cells, at the very interface
betweenmaternal blood and fetus [21].
Fig 3. Western blot analysis of proteins involved in intracellular pathway initiated by D6 engagement by active ligands and leading to cofilin-
inactivation and actin filaments depolymerization. Phosphorylated (p)-LIMK1 (A) and p-Cofilin (B) were increased in trophoblast cell lysates from PE
patients compared to controls. GAPDH: glyceraldehyde-3-phosphate dehydrogenase (loading control). Results are expressed as mean ± SE of six
experiments. *p<0.05.
doi:10.1371/journal.pone.0164747.g003
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In fact, implantation process is associated with a robust maternal inflammatory response
that is maintained throughout pregnancy and characterized by maternal leukocyte recruitment
into the decidua [33,34]. This is thought to be a critical component of a successful pregnancy
but, given the semi-allogenic nature of fetal tissues, mechanisms must also be in place to pro-
tect trophoblasts frommaternal leukocyte attack.
This delicate balance may be compromised in pregnancy-related diseases such as PE, a pla-
centa-induced disorder characterized by exacerbated systemic inflammatory response [3–5].
Indeed, higher circulating blood levels of pro-inflammatory cytokines, like CCL2, IL-6, IL-8,
TNF-α and RANTES have been shown in PE [21, 23–25].
Particularly, Madigan and co-authors observeda trend of increase of circulatingD6-binding
chemokines levels in the third trimester of women later developing PE [21], although not
Fig 4. (A, B) Representative images of confocal analysis of CCL2 binding to D6 receptor in primary trophoblast cell cultures from normal
pregnant women (A) or women with PE (B). Cells from controls (A) showed higher CCL2 binding to D6 (green) compared to PE (B) quantified by
counting the number of fluorescent dots on the overall number of cells (C). Scale bar 20 μm. 4D. Functional assay of D6 receptor scavenging activity
revealed, in both controls and PE cells, a significant scavenging of CCL2 after 12 and 24 hours of incubation (*p<0.05 versus time 0). Interestingly, atr 24
hours, decreased CCL2 scavenging activity was observed in cells from PE compared to CTR (§p<0.05 versus CTR). Results are expressed as
mean ± SE of six experiments.
doi:10.1371/journal.pone.0164747.g004
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reaching a significant difference, probably because of the small sample of patients and timing
of blood sampling, not performed during overt PE.
Recently, Cho and coworkers showed decreased transcription and expression of D6 in pla-
centae from 23 women with PE compared to 12 controls, suggesting a role of reduced placental
expression of D6 in the exaggerated placental tissues inflammation typical of PE [35].
The aim of this study was to investigate circulatingD6-binding chemokines levels in overt
PE compared to term pregnancy controls and to compare, in the same women, placental
expression and function of D6 decoy receptor.
Since we did not find significant differences in D6 placental expression between PE women
and controls, neither in whole placental lysates nor in primary trophoblast cell lysates, we
investigated possible differences in terms of D6 receptor engagement, activation and distribu-
tion in trophoblast cell cultures.
Herein, we reported, for the first time to our knowledge, that D6 decoy receptor is up-regu-
lated in trophoblast cell membranes in PE compared to controls. This observation is consistent
with our finding of increased circulatingD6-chemokines in PE women compared to controls.
Fig 5. Confocal images of cytoskeleton F-actin fibers organization in primary trophoblast cell cultures from placentae of healthy pregnant
women at term (A-C) or women with PE (D-F). In PE trophoblast cells display a dramatic disarrangement and loss of spatial orientation of actin fibers
compared to controls. Scale bar 20 μm.
doi:10.1371/journal.pone.0164747.g005
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Indeed, in contrast to conventional chemokine receptors, after ligand engagement, D6 does
not decrease but rather increases its expression on the cell surface, due to its mobilization from
the intracellular pool, in particular by accelerating receptor recycling through the Rab11-posi-
tive vesicles [16]. Thus, constitutive cycling and ligand-dependent receptor up-regulation are
mechanisms allowing rapid modulation of ligand uptake and degradation [36]. We are per-
suaded that higher circulating levels of pro-inflammatory chemokines in PE might massively
bind to D6 decoy receptor at placental level and induce the scavenger up-regulation on tropho-
blast cell membranes, due to its mobilization from the intracellular pool.
Accordingly with increased trophoblast membrane expression of D6 receptor in PE, we
observed a stronger activation of D6 intracellular LIMK1-cofilin signaling pathway, as a logical
consequence of a higher chemokines-D6 binding on cell membranes, previously occurred in
PE placentae in vivo.
In physiological conditions, phospholrylation, and thus, inactivation of cofilin would enable
actin network rearrangements, critically required to mobilize the receptor from intracellular
compartments, to increase in its abundance on the plasma membrane and its scavenging activ-
ity [18].
Interestingly, when adding exogenous CCL2 to primary trophoblast cell cultures, we noticed
a reduced binding to cells obtained from PE placentae compared to those from normal preg-
nancies. This observationmight be explained by the higher saturation of D6 receptor in PE tro-
phoblast cells, probably due to local and systemic pro-inflammatory environment occurring in
the syndrome. Surprisingly, when investigating D6 receptor from a functional point of view,
we observed a reduced trophoblasts D6 scavenging ability in PE.
Since cytoskeleton is crucial for D6 intracellular trafficking and functionality, we studied F-
actin organization in trophoblast cells and we discovered a dramatic disarrangement of cyto-
skeleton in PE compared to controls.Indeed, mobilization of D6 from intracellular endosomes
and vesicles trafficking relies on the regulatory and motor proteins of the cytoskeleton [16,37].
Therefore, a dynamic actin cytoskeleton is required to sustain D6-mediated uptake and target-
ing of chemokine for degradation.
Overall, our results suggest that in all cases of PE, an impairment of trophoblast cells cyto-
skeleton, as a consequence of several potential injures, like syncytiotrophoblast oxidative stress
[38], might occur and affect D6 function, that is, in the meantime, overstressed by increased
D6-binding chemokines secretion. It is important to remark that syncytiotrophoblast stress,
and thus cytoskeleton impairment, might take place, at different times, in both “placental” and
“maternal” cases of PE, the first due to severe poor placentation, manifesting early in pregnancy
and generally associated to intrauterine growth restriction, the last characterized by later onset
and generally appropriate fetal growth, occurringwhen a placenta is working, supplying blood
to the fetus, at the upper limits of its functional reserve [39].
The final effect can lead to impairment of cell cytoskeleton, that cannot allow neither che-
mokines degradation nor D6 receptor recycling, causing deficient regulation of inflammatory
environment at maternal-fetal interface. This is consistent with the observation in trophoblast
membranes isolated from PE placentae of higher expression of D6 but lower binding and scav-
enging of exogenously added CCL2. In fact, D6 mobilized to membrane surface for the
increased levels of circulating chemokines, is mostly saturated by endogenous chemokines and
is no more able, because of cytoskeleton injury, to degrade CCL2 or recycle intracellular D6
receptor.
These phenomena might result in increased inflammation-inducedplacental impairment
and systemic inflammatory response, worsening placental function and, thus, maternal-fetal
outcome in PE.
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Supporting Information
S1 Fig. Western blot analysis of both D6 and the cytosolicmarker GAPDH in trophoblast
whole cells (A) or plasmamembrane (B) lysates. The dramatic reduction of intensity of the
GAPDH band in lysates of trophoblast plasma membrane samples (B) is an indirect proof of
the effectiveness of membrane isolation procedure used in this study.
(TIF)
S2 Fig. Confocalmicroscopy analysis D6 in trophoblast cells from a pre-eclampticwomen.
Sequenses of images acquired in the z—axis clearly show D6 distribution on trophoblast
plasma membrane. A) D6 fluorescent staining; B) electronic transmission only; C) overlay.
Scale bar 20 μm.
(TIF)
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